JPRN-C000000253已完成1 期
A phase I/II trial of HLA haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning - A phase I/II trial of HLA haploidentical minitransplantation
Health and Labour Sciences Research Grants, Research on Human Genome, Tissue Engineering, Ministry of Health, Labour and Welfare0 个研究点目标入组 25 人开始时间: 2005年10月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Allergy for the agents used in conditioning or GVHD prophylaxis 2) Positivity for HBs antigen and/or HIV antibody 3) Active lesions in CNS 4) Active infections 5) Patients who are considered as inappropriate with other reasons
研究者
相似试验
招募中
2 期
Clinical trial for HLA-haploidentical transplantation using alpha-beta T cell and B cell depletioJPRN-jRCTs032230287Iguchi Akihiro3
招募中
2 期
HLA-mismatched unrelated HCT using PTCyJPRN-jRCTs051220057Kuno Masatomo29
招募中
2 期
A phase II study of haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide as Graft versus Host Disease (GVHD) prophylaxisACTRN12617000151336St Vincent's Hospital Sydney70
进行中（未招募）
1 期
Multicenter Phase II study of haploidentical hematopoietic cell transplantation with CD3/CD19 depleted grafts after a reduced intensity conditioning regimen for adult patients with acute leukemia - Haplo CD3CD19-RICEUCTR2007-006016-33-DEniklinikum Tuebingen60
已完成
1 期
Phase I clinical trial of pan-HLA type personalized peptide vaccine for advanced pediatric malignant glioma patientsAdvanced pediatric malignant glioma patients who are refractory to standard therapiesJPRN-UMIN000000760Department of Immunology, Kurume University School of Medicine10